title: Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases.
abstract: Heme oxygenase (HO) is the rate-limiting enzyme in the catabolism of heme, followed by production of biliverdin, free iron and carbon monoxide (CO). There are three isoforms of HO: HO-1 is highly inducible, whereas HO-2 and HO-3 are constitutively expressed. In addition to heme, a variety of nonheme compounds, including heavy metals, cytokines, endotoxins and heat shock stress are strong inducers of HO-1 expression. Many studies indicated that induction of HO-1 is associated with a protective response due to the removal of free heme, which is shown to be toxic. However, recent studies demonstrated that the expression of HO-1 in response to different inflammatory mediators could contribute in part to the resolution of inflammation and have protective effects on brain, liver, kidney and lung against injuries. These beneficial effects seem to be due to the production of bile pigment biliverdin and bilirubin that is a potent antioxidant, as well as the release of iron and CO. However, there are few studies concerning the relationship between HO-1 and inflammation as well as injury in the gut. Interestingly, a preliminary study implicated that induction of HO-1 expression in a colonic damage model induced by trinitrobenzene sulfonic acid played a critical protective role, indicating that activation of HO-1 could act as a natural defensive mechanism to alleviate inflammation and tissue injury in the gastrointestinal tract.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, The University of Hong Kong, SAR, PR China.
authors.forename: X
authors.initials: X
authors.lastname: Guo
authors.forename: V Y
authors.initials: VY
authors.lastname: Shin
authors.forename: C H
authors.initials: CH
authors.lastname: Cho
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000201:enzymology; D003106:Colon / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D019610:Cytoprotection / Q000187:drug effects; D004195:Disease Models, Animal; D004790:Enzyme Induction; D005767:Gastrointestinal Diseases / Q000201:enzymology* / Q000517:prevention & control; D006419:Heme Oxygenase (Decyclizing) / Q000096:biosynthesis*; D051547:Heme Oxygenase-1; D006801:Humans; D007249:Inflammation / Q000201:enzymology; D007668:Kidney / Q000201:enzymology / Q000293:injuries; D008099:Liver / Q000201:enzymology / Q000293:injuries; D008297:Male; D008565:Membrane Proteins; D051381:Rats; D015427:Reperfusion Injury / Q000201:enzymology; D014302:Trinitrobenzenesulfonic Acid / Q000494:pharmacology; D014947:Wounds and Injuries / Q000201:enzymology*
chemical_list: D008565:Membrane Proteins; D014302:Trinitrobenzenesulfonic Acid; C496541:HMOX1 protein, human; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1